Intravesical Instillation of Botulinum Toxin Type A to Patients With Urge Urinary Incontinence

Sponsor
Glostrup University Hospital, Copenhagen (Other)
Overall Status
Unknown status
CT.gov ID
NCT00770406
Collaborator
(none)
20
1
17
1.2

Study Details

Study Description

Brief Summary

A pilot study to examine efficacy and safety of intravesical botulinum toxin type A.

Condition or Disease Intervention/Treatment Phase
  • Drug: botulinum toxin type A
Phase 1/Phase 2

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Intravesikal Instillation af Botulinum Toxin Type A Til Patienter Med Urge Urininkontinens
Study Start Date :
Jan 1, 2009
Anticipated Primary Completion Date :
Jun 1, 2010
Anticipated Study Completion Date :
Jun 1, 2010

Outcome Measures

Primary Outcome Measures

  1. Incontinence episode frequency [1 year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • refractory urge urinary incontinence
Exclusion Criteria:
  • neurological disease

  • pregnant or lactating

  • bladder neoplasias

Contacts and Locations

Locations

Site City State Country Postal Code
1 Glostrup Hospital Glostrup Copenhagen Denmark DK-2600

Sponsors and Collaborators

  • Glostrup University Hospital, Copenhagen

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00770406
Other Study ID Numbers:
  • BTXA2008
First Posted:
Oct 10, 2008
Last Update Posted:
Aug 4, 2009
Last Verified:
Aug 1, 2009

Study Results

No Results Posted as of Aug 4, 2009